Print Friendly and PDF
Share this:  

June 23, 2011

On June 23 , Kelly et al’s study on the survival of PNH patients being treated with Soliris was published in the print edition of Blood. The publication of the study confirms that Soliris “dramatically alters the natural course of PNH, reducing symptoms and disease complications as well as improving survival to a similar level to that of the general population.” The full study also appears online.